As a patient, receiving a diagnosis of prostate cancer can be overwhelming and cause various emotions such as fear, confusion, and uncertainty. It is important to know that you are not alone in this journey and seeking a second opinion can provide valuable insight and peace of mind.
In recent years, advancements in technology have allowed for the integration of artificial intelligence (AI) in healthcare, particularly in the field of oncology. AI has shown promising results in improving diagnostic accuracy and treatment planning for prostate cancer patients.
Prostate cancer is the most commonly diagnosed cancer among men worldwide. It is estimated that over 191,000 men will be diagnosed with prostate cancer in the United States alone this year. With such a high prevalence, it is crucial to have access to the latest technology and expertise when facing a prostate cancer diagnosis.
MaleScan™ utilizes ProstatID’s AI algorithms to analyze medical imaging data (MRI) to provide you and your doctors with a comprehensive second opinion report.
By utilizing PPC’s AI-supported second opinion service, patients can have confidence in their diagnosis and treatment plan. The integration of AI technology provides an added layer of precision and thoroughness that may not be achievable through traditional methods alone.
If you have access to your MRI scan, you can submit it directly to us and receive an AI-supported diagnostic report within minutes. This report can be shared with your doctor.
If you don’t have access to your MRI, we can provide you with instructions you can give to your imaging provider or doctor to upload it on your behalf.
